- Development of lead candidate AlloNK (AB-101) discontinued due to insufficient response durability.
- Workforce reduced by approximately 94%; Leerink Partners engaged for strategic alternatives.
- Preliminary cash, cash equivalents, and investments reported at $319.1 million as of Sept 30, 2026.
?? Negative AI Sentiment (-9.2 / 10)